You are warned. Sinovac turns umno leaders into mandarin speakers.

[syed putra]

https://www.therakyatpost.com/2021/03/18/kjs-mandarin-becomes-hot-topic-among-netizens/

 

[syed putra]

This is treason. Chinese schools in jiu hu should be abolished like in sinkie.

 

[Cottonmouth]

Can tell that his IQ increased 10%
he want to eat xiaolongbao?

 

[syed putra]

Can tell that his IQ increased 10%
he want to eat xiaolongbao?

You mean char siew pau?

 

[Cottonmouth]

You mean char siew pau?

Slowly mister, start small.

 

[laksaboy]

Netizens were impressed by his performance and even attributed his linguistic prowess to the China-made vaccine.

Looks like China paid for the whole event to paint its vaccines in a positive light. Sad!

 

[Hypocrite-The]

Oh no. Cantos are goners....but indon land cina r fuckeins. So they suck up to mandarin chicoms is no surprise

 

[Hypocrite-The]

Theindependent
How can one learn a new language in a few months, the boy asks


Author

- Advertisement -
Singapore — A Malay student from a polytechnic took to social media to air a problem he faced during an internship.

In an Instagram post shared on popular account @netiizenz, a boy can be seen lying down on the bed and shaking his head.

The short clip had Mandarin and Hokkien vulgarities repeated as the soundtrack playing in the background.

While the youth did not say anything for the duration of the clip, he had the following text superimposed on it: “When i told my poly lecturer i was having a diff time during internship cos they keep speaking chinese & she told me ‘to learn chinese’”.

- Advertisement -
He explained that, to fit in better during an internship, his lecturer allegedly told him to “learn chinese”.

It is unclear which polytechnic he was from, or who his lecturer was. The boy added: “Lol ok maam (sic) let me this malay boy magically pickup a whole new language in a few months”.

The national languages of Singapore are English, Mandarin, Malay and Tamil, but English is the medium of instruction in schools where the students are also taught their mother tongue as a second language.

In 2019, in a statement to CNA, the Tripartite Alliance for Fair and Progressive Employment Practices (TAFEP) said that while language discrimination complaints continue to exist at the workplace, the number has decreased over the years.

It added that complaints about alleged workplace discrimination related to language have been on a downward trend in the last five years. These complaints involved discriminatory job advertisements, interview processes, and HR practices, TAFEP said.

It received a total of 113 complaints on the matter between 2014 and 2018, with 31 cases in 2014 and 15 in 2018, said TAFEP.

Addressing concerns about job advertisements or interviews that may state preferred languages, TAFEP said: “The Tripartite Guidelines on Fair Employment Practices require employers to hire on the basis of merit and not use language as a limiting criterion during selection or recruitment.

“If the job requires the employee to use a specific language, the employer should justify how this criterion would apply, and affect the ability of the employee to perform the job.” /TISGFollow us on Social Media

Facebook
Twitter
Instagram
YouTube
Reddit
LinkedIn
Telegram
Email
Send in your scoops to [email protected]
- Advertisement -⁸

 

[Hypocrite-The]

After taking Sinovac shot, Khairy announces in Mandarin that all Covid-19 vaccines are safe | Malay Mail
Science, Technology and Innovation Minister Khairy Jamaluddin receiving the Sinovac Covid-19 vaccine. — Picture courtesy of Twitter
Science, Technology and Innovation Minister Khairy Jamaluddin receiving the Sinovac Covid-19 vaccine. — Picture courtesy of Twitter
Subscribe to our Telegram channel for the latest updates on news you need to know.

KUALA LUMPUR, Mar 18 — Science, Technology and Innovation Minister Khairy Jamaluddin announced in Mandarin today that the Sinovac Covid-19 vaccine from China he received was safe, as were others approved for use in Malaysia.

ADVERTISEMENT

In a 24-second video posted on Twitter, Khairy joked that the Sinovac vaccine has also improved his command of Mandarin.

“I feel good. No matter what kind of vaccine it is, it is safe. Let us defeat the virus together. Protect yourself, protect everyone!” he said.

ADVERTISING
Malaysia commenced its national Covid-19 inoculation programme on February 24, using the vaccine manufactured by American pharmaceutical corporation Pfizer and its German partner BioNTech.

On February 27 the final batch of the Sinovac vaccine supply arrived in the country, where it will be processed by domestic pharmaceutical corporation Pharmaniaga LifeScience Sdn Bhd in bulk.

Subsequently on March 2, Putrajaya granted conditional approval to Sinovac along with the vaccine from UK firm AstraZeneca.

 

[Loofydralb]

Can tell that his IQ increased 10%
he want to eat xiaolongbao?

Soon he will spit, cuss and defecate in public

 

[zeddy]

This is treason. Chinese schools in jiu hu should be abolished like in sinkie.

Many Malays are sending their kids to Chinese schools. Surprisingly, even the rural Malays are doing that. They know their kids stand to gain by learning Mandarin, Malay and English. An Ipoh female school teacher friend of mine told me this back then.

 

[zeddy]

KJ is one of those rare UMNO chaps who are articulate and fluent in English and is progressive in his thinking. But too bad he doesn't not have any support within UMNO since the kampung warlords still wield power and influence within the party.

 

[A Singaporean]

This m&d knows that bacon makes you smarter.

 

[Leckmichamarsch]

another anti Chinese rant by SHIT POOtra the evil muslim

 

[syed putra]

This m&d knows that bacon makes you smarter.

 

[Hypocrite-The]

Khairy calls up Harian Metro editor after headline deemed ‘damaging’ to Covid-19 vaccine rollout | Malay Mail

Rembau MP Khairy Jamaluddin says the headline of the article particularly had left negative and damaging impact towards the government's Covid-19 National Immunisation Programme, after it appeared to link the nurse’s death to the vaccine. — Picture by Farhan Najib
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, March 19 ― Science, Technology and Innovation Minister Khairy Jamaluddin said the he will call up the editor of local Malay daily Harian Metro after deeming an article it published on the death of a nurse to be “very irresponsible”.
Taking to Twitter, the Rembau MP said that the headline of the article particularly had left negative and damaging impact towards the government's Covid-19 National Immunisation Programme, after it appeared to link the nurse’s death to the vaccine.
“This headline is very irresponsible and has given a negative impact to the execution of the National Immunisation Programme.
“I will be calling up the editor today but damage is done based on the comments on Facebook and others. Thanks for nothing @hmetromy,” he posted, tagging the paper’s Twitter account.
The local Malay-language tabloid had yesterday published an article online with the headline in Malay meaning “Nurse who received vaccine dies of heart illness”.
ADVERTISING
At the time of writing, the tweet of the article is still up despite the backlash from readers and Khairy.
Yesterday, Health director-general Tan Sri Dr Noor Hisham Abdullah had already clarified that the death of the nurse was not linked to the vaccine she had received.
He reportedly said the nurse's death was due to cardiac arrest and not because she received the vaccine, adding that authorities have already examined the incident and found no link to her death with receiving the Pfizer-BioNTech vaccine on March 12.
According to reports yesterday, the nurse was found dead at her home in Kedah by her husband.
The woman had been with the neo-natal ward of Hospital Pulau Pinang and received her Covid-19 vaccine earlier this month as part of the first phase of the National Immunisation Programme.
Links were made to the vaccination after reports cited a police official as saying that the husband informed a medical officer that the nurse fell ill a day after receiving her vaccine.
As in other countries, Putrajaya, through the National Pharmaceutical Regulatory Authority, reviews the safety of all Covid-19 vaccines before they are approved for use.

 

[Hypocrite-The]

HSA starts review of Sinovac COVID-19 vaccine
A worker performs a quality check of the Sinovac Biotech COVID-19 vaccine during a government-organised media tour in Beijing, China, Sep 24, 2020. (File photo: REUTERS/Thomas Peter)Bookmark
SINGAPORE: The Health Sciences Authority (HSA) said on Monday (Mar 22) it has started reviewing data on China's Sinovac COVID-19 vaccine.
It has also asked the biopharmaceutical company for additional data and is waiting for it, said HSA in response to CNA queries.
Singapore received its first shipment of the Sinovac vaccine on Feb 23. HSA said then that Sinovac had started submitting initial data, and that it was awaiting the submission of all necessary information to carry out its assessment.
The vaccine developed by China's Sinovac Biotech has been approved for general use in China, and is already in use in Hong Kong, Indonesia, Malaysia and Thailand.
In Singapore, the Sinovac vaccine is being evaluated but has not yet been authorised for use, said HSA.
"HSA has requested from the company additional data required to assess if it can meet the required standards for quality, safety and efficacy for interim authorisation under the Pandemic Special Access Route, and is still waiting for the company to submit the data," said the authority.
READ: Pfizer-BioNTech, Moderna and Sinovac – A look at three key COVID-19 vaccines
On Monday, HSA said that it has also been in talks with various companies, including AstraZeneca, on their submission plans for COVID-19 vaccines.
"All vaccines are rigorously evaluated by HSA on their quality, safety and efficacy before they are approved for use in Singapore," said the authority.
More than a dozen countries suspended the use of AstraZeneca vaccines earlier this month, after reports of blood clotting among some recipients in Europe.
Many countries – including France, Germany and Indonesia – have since said they will resume use of the AstraZeneca vaccine, after an investigation by the European Medicines Agency concluded that the benefits outweighed the risks.
READ: AstraZeneca COVID-19 vaccine is 'haram', but permissible due to urgent situation – Indonesia Islamic body
Singapore has so far authorised two COVID-19 vaccines for use.
The country started its vaccination drive in December with the Pfizer-BioNTech jab, the first vaccine to arrive in Singapore.
Moderna's vaccine was approved for use in early February, with the first shipment arriving two weeks later.

 

[laksaboy]

LOL... only start reviewing now after having already bought them so many months ago?

Even the Tiong embassy did its little social media victory dance when the vaccines were delivered.

"Didn't get pressured by China"... yeah right, just like Joey Mendoza didn't steal the song.

 

[Hypocrite-The]

LOL... only start reviewing now after having already bought them so many months ago?

Even the Tiong embassy did its little social media victory dance when the vaccines were delivered.

"Didn't get pressured by China"... yeah right, just like Joey Mendoza didn't steal the song.

I doubt pap will want to deal with the repercussions of using the tiong vaccine. It was their own stupidity in buying the tiong stuff. Which other developed nation using the CCP Virus vaccine? Want to plp also got to smart about it lah...

 

[Hypocrite-The]

Sinovac: Brazil results show Chinese vaccine 50.4% effective
Published13 January
Share
Related Topics

• Coronavirus pandemic

IMAGE COPYRIGHTGETTY IMAGES
image captionThe Chinese vaccine is one of two that the Brazilian government has lined up
A coronavirus vaccine developed by China's Sinovac has been found to be 50.4% effective in Brazilian clinical trials, according to the latest results released by researchers.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval.
The Chinese vaccine is one of two that the Brazilian government has lined up.
Brazil has been one of the countries worst affected by Covid-19.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response.
Several countries, including Indonesia, Turkey and Singapore, have placed orders for the vaccine.

• What do we know about China's Covid-19 vaccines?
• How do I know the Covid vaccine is safe?

Last week researchers at the Butantan Institute, which has been conducting the trials in Brazil, announced that the vaccine had a 78% efficacy against "mild-to-severe" Covid-19 cases.
But on Tuesday they revealed that calculations for this figure did not include data from a group of "very mild infections" among those who received the vaccine that did not require clinical assistance.

ADVERTISEMENT


With the inclusion of this data, the efficacy rate is now 50.4%, said researchers.
But Butantan stressed that the vaccine is 78% effective in preventing mild cases that needed treatment and 100% effective in staving off moderate to serious cases.
The Sinovac trials have yielded different results across different countries.
Last month Turkish researchers said the Sinovac vaccine was 91.25% effective, while Indonesia, which rolled out its mass vaccination programme on Wednesday, said it was 65.3% effective. Both were interim results from late-stage trials.

Can vaccines be compared?
By Philippa Roxby, BBC Health reporter
The latest figures for China's coronavirus vaccine show just how difficult it is to compare vaccines.
On the face of it, the 50% effectiveness figure isn't as good as Oxford's 70% or Pfizer and Moderna's 95%. But trials are run very differently in different countries - the numbers of volunteers enrolled varies wildly, as do the criteria used to test how much protection the vaccines offer.
A figure for efficacy is reached by looking at how many people developed Covid after being given the vaccine, compared with how many were affected when given a dummy injection. Normally, that is based on people developing obvious symptoms but in this Brazilian trial, people with no symptoms also appear to have been included.
So it's only when the full data from all trials of this vaccine are published that scientists can analyse its real efficacy, and compare like with like. Only limited data for this Sinovac vaccine is currently available - and experts say that is confusing the picture.
In the long term, many vaccines against Covid are needed to vaccinate the world and, inevitably, some will perform better than others - but giving as many people as possible some protection is the priority.

There has been concern and criticism that Chinese vaccine trials are not subject to the same scrutiny and levels of transparency as its Western counterparts.
Both the Sinovac vaccine and the vaccine developed by Oxford University and pharmaceutical firm AstraZeneca have requests for emergency use authorisation pending with regulators in Brazil.

media captionFrom fear to freedom: China's painful year fighting Covid-19
The latest news comes as Brazil is dealing with a major spike in cases. The country currently has the third highest number of Covid-19 cases in the world at over 8.1 million, just behind the US and India.
The BBC World Service's Americas editor Candace Piette says the country is suffering one of the world's deadliest outbreaks but as yet, has not announced when its vaccination programme will begin.
The delay has been caused in large part by the government's haphazard and divided approach to vaccination, says our correspondent.